The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
The Centers for Medicare and Medicaid Services wants more evidence about the effectiveness of the medication lecanemab before it will cover the drug for Medicare patients suffering from the early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback